Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
RVL Pharmaceuticals (RVLPQ)
OTHER OTC:RVLPQ
Holding RVLPQ?
Track your performance easily
RVLPQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range<$0.01 - $0.03
Previous Close$0.01
Volume10.10K
Average Volume (3M)N/A
Market Cap
$111.00
Enterprise Value$58.15M
Total Cash (Recent Filing)$0.00
Total Debt (Recent Filing)$58.15M
Price to Earnings (P/E)―
Beta257.80
Next Earnings
Aug 12, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.70
Shares Outstanding111,410,000
10 Day Avg. Volume1,509
30 Day Avg. VolumeN/A
Standard Deviation21.79
R-Squared0.00408
Alpha4.48
Financial Highlights & Ratios
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
Price to Cash Flow (P/CF)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue1.57
Enterprise Value/Gross Profit1.44
Enterprise Value/Ebitda-0.84
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
RVL Pharmaceuticals News
PremiumCompany Announcements
RVL Pharmaceuticals Ordered to Liquidate by Irish High Court
Ownership Overview
―
Insiders
13.86% Other Institutional Investors
86.14% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
RVLPQ FAQ
What was RVL Pharmaceuticals’s price range in the past 12 months?
RVL Pharmaceuticals lowest stock price was <$0.01 and its highest was $0.03 in the past 12 months.
What is RVL Pharmaceuticals’s market cap?
Currently, no data Available
When is RVL Pharmaceuticals’s upcoming earnings report date?
RVL Pharmaceuticals’s upcoming earnings report date is Aug 12, 2024 which is 88 days ago.
How were RVL Pharmaceuticals’s earnings last quarter?
Currently, no data Available
Is RVL Pharmaceuticals overvalued?
According to Wall Street analysts RVL Pharmaceuticals’s price is currently Overvalued.
Does RVL Pharmaceuticals pay dividends?
RVL Pharmaceuticals does not currently pay dividends.
What is RVL Pharmaceuticals’s EPS estimate?
RVL Pharmaceuticals’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does RVL Pharmaceuticals have?
RVL Pharmaceuticals has 111,406,044 shares outstanding.
What happened to RVL Pharmaceuticals’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of RVL Pharmaceuticals?
Among the largest hedge funds holding RVL Pharmaceuticals’s share is Blackstone Inc.. It holds RVL Pharmaceuticals’s shares valued at N/A.
---
RVL Pharmaceuticals Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Company Description
RVL Pharmaceuticals
Osmotica Pharmaceuticals Plc operates as a biopharmaceutical company, which engages in the development and commercialization of specialty products for neurology and women's health. Its products include M-72, Lorzone, ConZip, OB Complete, and Divigel. The company was founded in 1986 and is headquartered in Bridgewater, NJ.
---
RVLPQ Earnings Call
Q2 2023
0:00 / 0:00
---
RVLPQ Stock 12 Month Forecast
Average Price Target
―---